PTC has received the Enzyme Targeting Therapeutics Innovation of the Year in the 6th annual BioTech Breakthrough Awards for our treatment for PKU. We're proud to have recognition of our therapy designed to expand options for patients living with this lifelong metabolic condition.
PTC Therapeutics
@PTCBio
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare disease
293 Following 2.4K Followers 1.5K Posts
Latest posts 5
PTC's President & CEO Matthew Klein, MD and CFO Pierre Gravier will speak at two upcoming investor conferences to close out the year. Learn more: ow.ly/O5yv5102X14
Today we announced our Q3 2026 financial results where we highlighted our continued commercial momentum and raised full-year revenue guidance. Read the press release: ow.ly/CVBZ5102ghh | Webcast: ow.ly/23Qw5102ghi
PTC will host a web conference to report our third quarter 2026 financial results and provide an update on the company’s business on Thursday, Oct. 29, 2026, at 4:30 p.m. ET. Learn more: ow.ly/hHoP50ZY969
Hello, #FabryDisease community. We're honored to introduce ourselves as we advance the investigational gene therapy ST-920 with an FDA submission planned before the end of 2026. Read our letter to the community: ow.ly/XhNx50ZTegw